FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162213774> ?p ?o ?g. }

• W2162213774 endingPage "2379" @default.
• W2162213774 startingPage "2372" @default.
• W2162213774 abstract "KIT receptor tyrosine kinase mutations are implicated as a prognostic factor in adults with core binding factor (CBF) acute myeloid leukemia (AML). However, their prevalence and prognostic significance in pediatric CBF AML is not well established. We performed KIT mutational analysis (exon 8 and exon 17) on diagnostic specimens from 203 pediatric patients with CBF AML enrolled on 4 pediatric AML protocols. KIT mutations were detected in 38 (19%) of 203 (95% CI, 14%-25%) patient samples of which 20 (52.5%) of 38 (95% CI, 36%-69%) involved exon 8, 17 (45%) of 38 (95% CI, 29%-62%) involved exon 17, and 1 (2.5%; 95% CI, 0%-14%) involved both locations. Patients with KIT mutations had a 5-year event-free survival of 55% (± 17%) compared with 59% (± 9%) for patients with wild-type KIT (P = .86). Rates of complete remission, overall survival, disease-free survival, or relapse were not significantly different for patients with or without KIT mutations. Location of the KIT mutation and analysis by cytogenetic subtype [t(8;21) vs inv(16)] also lacked prognostic significance. Our study shows that KIT mutations lack prognostic significance in a large series of pediatric patients with CBF AML. This finding, which differs from adult series and a previously published pediatric study, may reflect variations in therapeutic approaches and/or biologic heterogeneity within CBF AML. Two of 4 studies included in this analysis are registered at http://clinicaltrials.gov as NCT00002798 (CCG-2961) and NCT00070174 (COG AAML03P1)." @default.
• W2162213774 created "2016-06-24" @default.
• W2162213774 creator A5007262193 @default.
• W2162213774 creator A5009716898 @default.
• W2162213774 creator A5012776569 @default.
• W2162213774 creator A5018786888 @default.
• W2162213774 creator A5021003209 @default.
• W2162213774 creator A5021059238 @default.
• W2162213774 creator A5027364145 @default.
• W2162213774 creator A5027519120 @default.
• W2162213774 creator A5033728889 @default.
• W2162213774 creator A5035790918 @default.
• W2162213774 creator A5049490094 @default.
• W2162213774 creator A5050992845 @default.
• W2162213774 creator A5062366315 @default.
• W2162213774 creator A5066861312 @default.
• W2162213774 creator A5069036596 @default.
• W2162213774 creator A5071641198 @default.
• W2162213774 creator A5075827511 @default.
• W2162213774 creator A5079129042 @default.
• W2162213774 creator A5081765963 @default.
• W2162213774 creator A5082967648 @default.
• W2162213774 creator A5089541690 @default.
• W2162213774 creator A5091057405 @default.
• W2162213774 date "2010-03-25" @default.
• W2162213774 modified "2023-10-05" @default.
• W2162213774 title "Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML" @default.
• W2162213774 cites W1534965621 @default.
• W2162213774 cites W1972978214 @default.
• W2162213774 cites W1983184427 @default.
• W2162213774 cites W1983595291 @default.
• W2162213774 cites W1988108713 @default.
• W2162213774 cites W1998548135 @default.
• W2162213774 cites W2000507573 @default.
• W2162213774 cites W2004299093 @default.
• W2162213774 cites W2010955721 @default.
• W2162213774 cites W2015581521 @default.
• W2162213774 cites W2022307983 @default.
• W2162213774 cites W2033978466 @default.
• W2162213774 cites W2040399202 @default.
• W2162213774 cites W2040429996 @default.
• W2162213774 cites W2041715533 @default.
• W2162213774 cites W2045955813 @default.
• W2162213774 cites W2051853465 @default.
• W2162213774 cites W2055671553 @default.
• W2162213774 cites W2055764602 @default.
• W2162213774 cites W2073140442 @default.
• W2162213774 cites W2086404440 @default.
• W2162213774 cites W2094912768 @default.
• W2162213774 cites W2095023562 @default.
• W2162213774 cites W2110828128 @default.
• W2162213774 cites W2126283967 @default.
• W2162213774 cites W2135429827 @default.
• W2162213774 cites W2135551827 @default.
• W2162213774 cites W2136757448 @default.
• W2162213774 cites W2142316835 @default.
• W2162213774 cites W2153711368 @default.
• W2162213774 cites W2155376978 @default.
• W2162213774 cites W2159289068 @default.
• W2162213774 cites W2594566872 @default.
• W2162213774 cites W41335094 @default.
• W2162213774 cites W4293241248 @default.
• W2162213774 doi "https://doi.org/10.1182/blood-2009-09-241075" @default.
• W2162213774 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2845895" @default.
• W2162213774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20056794" @default.
• W2162213774 hasPublicationYear "2010" @default.
• W2162213774 type Work @default.
• W2162213774 sameAs 2162213774 @default.
• W2162213774 citedByCount "155" @default.
• W2162213774 countsByYear W21622137742012 @default.
• W2162213774 countsByYear W21622137742013 @default.
• W2162213774 countsByYear W21622137742014 @default.
• W2162213774 countsByYear W21622137742015 @default.
• W2162213774 countsByYear W21622137742016 @default.
• W2162213774 countsByYear W21622137742017 @default.
• W2162213774 countsByYear W21622137742018 @default.
• W2162213774 countsByYear W21622137742019 @default.
• W2162213774 countsByYear W21622137742020 @default.
• W2162213774 countsByYear W21622137742021 @default.
• W2162213774 countsByYear W21622137742022 @default.
• W2162213774 countsByYear W21622137742023 @default.
• W2162213774 crossrefType "journal-article" @default.
• W2162213774 hasAuthorship W2162213774A5007262193 @default.
• W2162213774 hasAuthorship W2162213774A5009716898 @default.
• W2162213774 hasAuthorship W2162213774A5012776569 @default.
• W2162213774 hasAuthorship W2162213774A5018786888 @default.
• W2162213774 hasAuthorship W2162213774A5021003209 @default.
• W2162213774 hasAuthorship W2162213774A5021059238 @default.
• W2162213774 hasAuthorship W2162213774A5027364145 @default.
• W2162213774 hasAuthorship W2162213774A5027519120 @default.
• W2162213774 hasAuthorship W2162213774A5033728889 @default.
• W2162213774 hasAuthorship W2162213774A5035790918 @default.
• W2162213774 hasAuthorship W2162213774A5049490094 @default.
• W2162213774 hasAuthorship W2162213774A5050992845 @default.
• W2162213774 hasAuthorship W2162213774A5062366315 @default.
• W2162213774 hasAuthorship W2162213774A5066861312 @default.
• W2162213774 hasAuthorship W2162213774A5069036596 @default.
• W2162213774 hasAuthorship W2162213774A5071641198 @default.

• next